Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renalytix Ai Plc ADR (NQ: RNLX )

2.420 +0.170 (+7.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,399
Open 2.330
Bid (Size) 2.400 (1)
Ask (Size) 2.430 (5)
Prev. Close 2.250
Today's Range 2.270 - 2.430
52wk Range 1.050 - 8.500
Shares Outstanding 74,891,844
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
From Renalytix plc
Via Globe NewsWire

Performance

YTD
+25.39%
+25.39%
1 Month
-29.65%
-29.65%
3 Month
+29.41%
+29.41%
6 Month
+89.06%
+89.06%
1 Year
-65.03%
-65.03%

More News

Read More
Renalytix AI Earnings Preview
Via Benzinga
Preview: Renalytix AI's Earnings
Via Benzinga
Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
From Renalytix plc
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Renalytix plc
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Renalytix announces a c.$20.3 million private placement
From Renalytix plc
Via Globe NewsWire
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
From Renalytix plc
Via Globe NewsWire
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
From Renalytix AI, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes
From Renalytix AI, Inc.
Via Globe NewsWire
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
From Renalytix AI, Inc.
Via Globe NewsWire
Earnings Scheduled For November 30, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
From Renalytix AI, Inc.
Via Globe NewsWire
Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
From Renalytix plc
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Renalytix to Present at Stifel Healthcare Conference
From Renalytix plc
Via Globe NewsWire
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.